AU5709698A - Methods for treating insulin resistance and identifying patients at risk for thedisease - Google Patents

Methods for treating insulin resistance and identifying patients at risk for thedisease

Info

Publication number
AU5709698A
AU5709698A AU57096/98A AU5709698A AU5709698A AU 5709698 A AU5709698 A AU 5709698A AU 57096/98 A AU57096/98 A AU 57096/98A AU 5709698 A AU5709698 A AU 5709698A AU 5709698 A AU5709698 A AU 5709698A
Authority
AU
Australia
Prior art keywords
thedisease
risk
methods
insulin resistance
identifying patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU57096/98A
Inventor
Fred I. Chasalow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amur Pharmaceuticals Inc
Original Assignee
Amur Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amur Pharmaceuticals Inc filed Critical Amur Pharmaceuticals Inc
Publication of AU5709698A publication Critical patent/AU5709698A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Rehabilitation Therapy (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Biotechnology (AREA)
  • Obesity (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
AU57096/98A 1996-12-24 1997-12-23 Methods for treating insulin resistance and identifying patients at risk for thedisease Abandoned AU5709698A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US3450496P 1996-12-24 1996-12-24
US60034504 1996-12-24
US3741797P 1997-02-21 1997-02-21
US60037417 1997-02-21
PCT/US1997/023481 WO1998027813A1 (en) 1996-12-24 1997-12-23 Methods for treating insulin resistance and identifying patients at risk for the disease

Publications (1)

Publication Number Publication Date
AU5709698A true AU5709698A (en) 1998-07-17

Family

ID=26711037

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57096/98A Abandoned AU5709698A (en) 1996-12-24 1997-12-23 Methods for treating insulin resistance and identifying patients at risk for thedisease

Country Status (5)

Country Link
EP (1) EP1009232A4 (en)
JP (1) JP2001508770A (en)
AU (1) AU5709698A (en)
CA (1) CA2276149A1 (en)
WO (1) WO1998027813A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220111011A1 (en) * 2020-10-13 2022-04-14 Betavive Ltd. Method and Compounds for Treating Diabetes and Associated Metabolic Diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8920381D0 (en) * 1989-09-08 1989-10-25 Greater Glasgow Health Board Treatment of insulin-resistant diabetes

Also Published As

Publication number Publication date
EP1009232A4 (en) 2002-06-12
WO1998027813A1 (en) 1998-07-02
CA2276149A1 (en) 1998-07-02
EP1009232A1 (en) 2000-06-21
JP2001508770A (en) 2001-07-03

Similar Documents

Publication Publication Date Title
AU7491698A (en) Apparatus and method for treating tissue with multiple electrodes
AU3514597A (en) Marker element for interstitial treatment and localizing device and method using same
AU2358895A (en) Medical electrode and method
AU2577299A (en) Implantable therapeutic device and method
AU1756097A (en) Medical applicator and method
AU6507999A (en) Catheter apparatus and method
AU3552195A (en) Improved patient-transport and treatment apparatus
AU4458697A (en) Use of leptin antagonists for treating insulin resistance in type ii diabetes
AU9486298A (en) Surgical apparatus and method
AU1487995A (en) Surgical lift method and apparatus
AU3955295A (en) Method and device for tissue resection
AU3066497A (en) Stereotactic surgical procedure apparatus and method
IL130157A0 (en) Temperature regulating catheter and methods
AU1077197A (en) Medical catheters for ablation and detection
GB9518888D0 (en) Device and method for transcutaneous surgery
AU1756597A (en) Medical syringe and self-retracting needle apparatus
AU3299197A (en) Method and device for treating muscular ailments
AU1967897A (en) Method for treatment of insulin resistance
AU3887599A (en) Medical analysis and treatment method and system
AU7104498A (en) Method and apparatus for collecting blood
AU5538396A (en) Medical tubing and assemblies
GB2330091B (en) Method and means for coating medical cannulas
AU4327899A (en) Protective kit for medical sharps and method for using same
AU4971499A (en) Medical diagnostic and treatment information system and method
AU1857397A (en) Method and system for identifying patients at risk for an adverse health outcome